ARCHIVES

BMS Execs Knew Of Flaws In ImClone Plan For C225 Prior To $2-Billion Licensing Deal

This article is from The Cancer Letter archive.

Vol. 28 No. 25 | June 21, 2002

Download PDF Visit The Full Archive

Related Articles

NCI Programs: Institute To Expand Career Development, Training Grants

December 18, 1998

In Brief: Discoverer Of H. Pylori Role In Ulcers Wins Lasker Foundation Clinical Research Award

October 6, 1995

Senate Committee Approves $27 Billion for NIH, $4.6 Billion for NCI

August 2, 2002

Adding Aresenic To Therapy Improves APL Survival

July 27, 2007

FDA Breakthrough Designation Granted to Pfizer’s Palbociclib

April 26, 2013

In Brief: House, Senate Authorization Measuring Waiting Floor Action; Money Bill Markups Pending

June 13, 1980